Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
VSIG10L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IGLON5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ETFB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLDND2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NKG7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LIM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C19orf84 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SIGLECL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIGLEC10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIGLEC8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIGLEC17P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIGLEC7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIGLEC9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLK14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLK13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on